Home > Buprenorphine treatment for young adults.

NIDA-SAMHSA Blending Initiative. (2010) Buprenorphine treatment for young adults. Bethesda, MD: NIDA-SAMHSA Blending Initiative.

PDF (Buprenorphine treatment for young adults: trainers manual) - Published Version
[img] Microsoft PowerPoint (Buprenorphine treatment for young adults: PowerPoint slides)

The materials listed here were developed by blending the resources and talent of researchers and community treatment providers from US-based NIDA's Clinical Trials Network and staff from SAMHSA/CSAT's ATTC Network. These materials promote the understanding and adoption of evidence based treatment interventions by professionals in the treatment field.

Primary Goal: Recent concern has focused on opioid use among youth, particularly non¬medical use of pain relievers.

This Blending product highlights the findings of the NIDA CTN study that compared longer term versus short-term buprenorphine/ naloxone treatment in an outpatient set¬ting. Primary results indicated that young adults in the longer term buprenor¬phine treatment were less likely to inject drugs or abuse opioids, cocaine, and marijuana, and were more likely to remain in treatment than those young adults who received short-term detoxification.

Blending Team products include:
Three-hour classroom training
PowerPoint presentation

Repository Staff Only: item control page